CA2324364A1 - Capsules d'amidon contenant des micro-organismes et/ou des polypeptides ou des proteines, et leur procede de production - Google Patents

Capsules d'amidon contenant des micro-organismes et/ou des polypeptides ou des proteines, et leur procede de production Download PDF

Info

Publication number
CA2324364A1
CA2324364A1 CA002324364A CA2324364A CA2324364A1 CA 2324364 A1 CA2324364 A1 CA 2324364A1 CA 002324364 A CA002324364 A CA 002324364A CA 2324364 A CA2324364 A CA 2324364A CA 2324364 A1 CA2324364 A1 CA 2324364A1
Authority
CA
Canada
Prior art keywords
starch
granules
granule
filled
organisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002324364A
Other languages
English (en)
Inventor
Paivi Myllarinen
Pirkko Forssell
Atte Von Wright
Minna Alander
Tiina Mattila-Sandholm
Kaisa Poutanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valtion Teknillinen Tutkimuskeskus
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2324364A1 publication Critical patent/CA2324364A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des capsules d'amidon protégeant diverses substances, telles que des enzymes ou des microbes vivants, contre les effets du milieu ambiant ou des intestins, ainsi qu'un procédé de production de ces capsules. On choisit parmi les granules d'amidon une fraction de taille appropriée, on améliore la porosité des granules par hydrolyse, et on remplit les granules de substances voulues, telles que des enzymes et/ou des microbes vivants. Le cas échéant, les granules d'amidon peuvent être recouvertes d'un biopolymère approprié, tel que l'amidon ou l'amylose.
CA002324364A 1998-03-27 1999-03-29 Capsules d'amidon contenant des micro-organismes et/ou des polypeptides ou des proteines, et leur procede de production Abandoned CA2324364A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI980707A FI104405B (fi) 1998-03-27 1998-03-27 Mikro-organismeja sisältävät tärkkelyskapselit ja niiden valmistusmenetelmä
FI980707 1998-03-27
PCT/FI1999/000259 WO1999052511A1 (fr) 1998-03-27 1999-03-29 Capsules d'amidon contenant des micro-organismes et/ou des polypeptides ou des proteines, et leur procede de production

Publications (1)

Publication Number Publication Date
CA2324364A1 true CA2324364A1 (fr) 1999-10-21

Family

ID=8551403

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002324364A Abandoned CA2324364A1 (fr) 1998-03-27 1999-03-29 Capsules d'amidon contenant des micro-organismes et/ou des polypeptides ou des proteines, et leur procede de production

Country Status (7)

Country Link
EP (1) EP1063976A1 (fr)
JP (1) JP2002511403A (fr)
AU (1) AU3038699A (fr)
BR (1) BR9909133A (fr)
CA (1) CA2324364A1 (fr)
FI (1) FI104405B (fr)
WO (1) WO1999052511A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
DE19962427A1 (de) * 1999-12-22 2001-07-12 Nutrinova Gmbh Verkapselte multifunktionelle, biologisch aktive Nahrungsmittelkomponente, Verfahren zu ihrer Herstellung und ihre Anwendung
KR100395633B1 (ko) * 2001-05-30 2003-08-21 문장조 다공성 전분을 내부 매트릭스로한 마이크로캡슐 및 그의제조방법
US20030198682A1 (en) * 2002-02-12 2003-10-23 Gruber James V. Composition and method for protecting labile active components during high temperature drying
US8871266B2 (en) * 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
JP2006280263A (ja) * 2005-03-31 2006-10-19 Snow Brand Milk Prod Co Ltd ビフィズス菌菌体粉末
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
EP2270131A1 (fr) 2005-05-31 2011-01-05 The Iams Company Lactobacilles probiotiques félins
PL2124966T3 (pl) 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
MY175316A (en) * 2011-01-25 2020-06-19 Austrianova Singapore Pte Ltd Protection of microbial cells from acidic degradation
CN111698912A (zh) * 2018-02-06 2020-09-22 日清富滋株式会社 马铃薯淀粉
CA3140303A1 (fr) * 2019-06-07 2020-12-10 Basf Se Nouvelles formulations de micro-organismes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160745A (en) * 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
US4859377A (en) * 1987-07-10 1989-08-22 The United States Of America, As Represented By The Secretary Of Agriculture Starch encapsulation of entomopathogens
US5403799A (en) * 1992-12-21 1995-04-04 W. R. Grace & Co.-Conn. Process upset-resistant inorganic supports for bioremediation
US5486507A (en) * 1994-01-14 1996-01-23 Fuisz Technologies Ltd. Porous particle aggregate and method therefor
GB2311027B (en) * 1996-03-15 1999-10-27 Johnson & Johnson Medical Coated bioabsorbable beads for wound treatment

Also Published As

Publication number Publication date
FI980707A0 (fi) 1998-03-27
EP1063976A1 (fr) 2001-01-03
AU3038699A (en) 1999-11-01
WO1999052511A1 (fr) 1999-10-21
FI980707A (fi) 1999-09-28
BR9909133A (pt) 2000-12-05
JP2002511403A (ja) 2002-04-16
FI104405B (fi) 2000-01-31

Similar Documents

Publication Publication Date Title
CA2324364A1 (fr) Capsules d'amidon contenant des micro-organismes et/ou des polypeptides ou des proteines, et leur procede de production
US4888171A (en) Granular product of dried microorganism cells and manufacturing method therefor
US9480276B2 (en) Dry food product containing live probiotic
AU694227B2 (en) Stabilized biologically active compounds contained in coated microgranules which can be suspended in alimentary fluids
EP1408760B1 (fr) Produit consommable contenant des probiotiques
JP5950938B2 (ja) マイクロカプセル化プロバイオティクス物質および製造方法
US20050266069A1 (en) Stable probiotic microsphere compositions and their methods of preparation
EP3205216A1 (fr) Microcapsules probiotiques multicouches
CN109700781A (zh) 一种靶向肠道的益生菌微胶囊及其制备方法
CA2825473A1 (fr) Protection de cellules microbiennes contre la degradation acide
Das et al. Microencapsulation of probiotic bacteria and its potential application in food technology
Harel et al. Protection and delivery of probiotics for use in foods
EP1713498A1 (fr) Composition contenant un materiau polymere et utilisations associees
US6514526B1 (en) Coated starch capsules and a process for producing them
EP2968579B1 (fr) Substances bioactives stables et procédés de fabrication
WO2019144979A1 (fr) Procédé de granulation et de recouvrement de probiotiques et noyau granuleux obtenu au moyen de celui-ci
JPH01196280A (ja) 多機能性食品及びその製造方法
KR102163637B1 (ko) 건강기능식품의 제조방법
KR100846672B1 (ko) 알지네이트/메틸-셀룰로우즈 캡슐을 이용한 바실러스폴리퍼멘티쿠스 ｓｃｄ의 생산성과 생존율 향상방법 및 그용도
FI104406B (fi) Tärkkelyskapselit ja niiden valmistusmenetelmä

Legal Events

Date Code Title Description
FZDE Dead